Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,211) with videos related to
Page
of 122
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2022
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer
K Van Baelen, T Geukens, M Maetens, et al.
British Journal of Cancer
|
April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
C Le Tourneau, X Paoletti, N Servant, et al.
Annals of Surgery
|
April 28, 2025
Frailty and Survival for Diagnoses Feasibly Managed Operatively or Nonoperatively
Emily Mosher, Hasan Nassereldine, Jeffrey C McKibben, et al.
JAMA Surgery
|
November 14, 2019
Association of Preoperative Patient Frailty and Operative Stress With Postoperative Mortality
Myrick C Shinall, Shipra Arya, Ada Youk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
P Tarantino, G Viale, M F Press, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification
K Rahmani Narj Abadi, C Dupain, I Guillou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2025
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer
K Van Baelen, E Sawyer, J Van Cauwenberge, et al.
The British Journal of Dermatology
|
December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey
S K Mahil, M Yates, S M Langan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival
Y Wang, D Drubay, S F Jonas, et al.
Communications Biology
|
August 4, 2025
fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experience
Meryem A Yücel, Robert Luke, Rickson C Mesquita, et al.
Page
of 122
Search research articles
Search
Showing results (1201-1210 of 1,211) with videos related to
Sort By:
Page
of 122
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 23, 2022
Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer
K Van Baelen, T Geukens, M Maetens, et al.
British Journal of Cancer
|
April 26, 2014
Randomised proof-of-concept phase II trial comparing targeted therapy based on tumour molecular profiling vs conventional therapy in patients with refractory cancer: results of the feasibility part of the SHIVA trial
C Le Tourneau, X Paoletti, N Servant, et al.
Annals of Surgery
|
April 28, 2025
Frailty and Survival for Diagnoses Feasibly Managed Operatively or Nonoperatively
Emily Mosher, Hasan Nassereldine, Jeffrey C McKibben, et al.
JAMA Surgery
|
November 14, 2019
Association of Preoperative Patient Frailty and Operative Stress With Postoperative Mortality
Myrick C Shinall, Shipra Arya, Ada Youk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 3, 2023
ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer
P Tarantino, G Viale, M F Press, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
The impact of targeted therapies on molecular alterations identified by an institutional molecular tumor board: an approach based on ESCAT classification
K Rahmani Narj Abadi, C Dupain, I Guillou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 23, 2025
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer
K Van Baelen, E Sawyer, J Van Cauwenberge, et al.
The British Journal of Dermatology
|
December 28, 2020
Risk-mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey
S K Mahil, M Yates, S M Langan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2026
Including tumor-infiltrating lymphocytes into the PREDICT prognostic model for triple-negative breast cancer survival
Y Wang, D Drubay, S F Jonas, et al.
Communications Biology
|
August 4, 2025
fNIRS reproducibility varies with data quality, analysis pipelines, and researcher experience
Meryem A Yücel, Robert Luke, Rickson C Mesquita, et al.
Page
of 122